Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study.

Bayer G, Agier MS, Lioger B, Lepelley M, Zenut M, Lanoue MC, Maillot F, Jonville-Bera AP

Open source

DOI
10.1016/j.ejim.2019.06.009
Published
2019 Sep
Container
European journal of internal medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejim.2019.06.009,
  title = {Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study.},
  author = {Bayer G and Agier MS and Lioger B and Lepelley M and Zenut M and Lanoue MC and Maillot F and Jonville-Bera AP},
  year = {2019},
  journal = {European journal of internal medicine},
  doi = {10.1016/j.ejim.2019.06.009},
  url = {https://doi.org/10.1016/j.ejim.2019.06.009}
}

RIS

TY  - JOUR
TI  - Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study.
AU  - Bayer G
AU  - Agier MS
AU  - Lioger B
AU  - Lepelley M
AU  - Zenut M
AU  - Lanoue MC
AU  - Maillot F
AU  - Jonville-Bera AP
PY  - 2019
JO  - European journal of internal medicine
DO  - 10.1016/j.ejim.2019.06.009
UR  - https://doi.org/10.1016/j.ejim.2019.06.009
ER  - 

APA

G, B., MS, A., B, L., M, L., M, Z., MC, L., F, M., & AP, J. (2019). Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study.. European journal of internal medicine. https://doi.org/10.1016/j.ejim.2019.06.009

Source records